Screener
Madrigal Pharmaceuticals, Inc. MDGL Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $12.38B.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s market capitalization?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported market capitalization of $12.38B in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s market capitalization changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s market capitalization increased by 95.6% year-over-year, from $6.33B to $12.38B.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s market capitalization has grown at a 47.4% compound annual growth rate (CAGR), from $1.9B to $13.23B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude